Has Jarrod Frizzell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $86,210 in general payments to Jarrod Frizzell, MD across 211 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jarrod Frizzell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jarrod Frizzell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jarrod Frizzell, MD

Interventional Cardiology · Evansville, INNPI 1457506545

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $61,083 of the $86,210 with a category attached, or 70.9%. 19 manufacturers reported payments, led by Boston Scientific at 43.7% of the total. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,210in general payments, 2019–2025

Across 211 payments — averaging $408.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$38K
Shockwave Medical, Inc$20K
Asahi Intecc USA, Inc.$19K
Medtronic$4K
Reflow Medical Inc$3K
Asahi Intecc CO., LTD.$630
plus $1K from 13 others

$472,981in research payments, 2019–2025

Across 71 payments — averaging $6661.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Gentuity, LLC$220K
M.a. Med Alliance S.A.$124K
Shockwave Medical, Inc$87K
Medtronic$39K
Medalliance LLC$3K

What the payments were for

Consulting fees$10,92513%
Speaking & faculty fees$61,08371%
Travel & lodging$2,9843%
Food & beverage$11,21813%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	61	$37,712
Shockwave Medical, Inc	16	$20,421
Asahi Intecc USA, Inc.	74	$18,706
Medtronic	25	$4,066
Reflow Medical Inc	8	$3,310
Asahi Intecc CO., LTD.	6	$630
Teleflex LLC	5	$514
Abbott	3	$190
Chiesi USA, Inc.	1	$145
Gentuity, LLC	1	$122
Edwards Lifesciences	1	$92
Philips North America LLC	2	$90
Seigla Medical, Inc.	1	$69
Verge Medical, Inc.	1	$50
Biotronik Inc.	2	$28
Abiomed	1	$26
Medline Industries LP	1	$18
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$15
Cardiovascular Systems Inc.	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$20,188
ASAHI PTCA Guide Wire$9,168
GENERAL VASCULAR ACCESS$8,472
GENERAL BALLOONS$7,500
PERIPHERAL VASCULAR$6,409
GENERAL - THERAPIES$2,188
AVVIGO Guidance System$1,354
Asahi Coronary Wires$1,250
RESOLUTE ONYX$1,160
ONYX FRONTIER$1,028
Asahi Peripheral Vascular Wires$330
GUIDELINER$311
SYMPLICITY G3$163
GENERAL - STENTS$156
MANTA$152
Xience Sierra Coronary Stent$144
CROSSBOSS$140
MAMBA$130
STINGRAY$128
Gentuity HF-OCT Imaging System$122

How this compares

$86,210 in reported general payments places this provider in the 95th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana →

Medicare billing

Part B allowed, 2024

$162,320

Medicare patients

226

Services billed

949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	24	$32,714
ClopidogrelClopidogrel Bisulfate	108	$1,259
Ranolazine ErRanolazine	24	$967
Metoprolol Succinate	56	$700
Rosuvastatin Calcium	27	$462
Atorvastatin Calcium	38	$376
Amlodipine Besylate	47	$257
Pantoprazole Sodium	17	$223
Cilostazol	13	$219
Isosorbide Mononitrate ErIsosorbide Mononitrate	18	$143
Atenolol	11	$108
Losartan Potassium	16	$37
Hydrochlorothiazide	16	$30
Prednisone	11	$14

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Evansville

Anthony VoelkelEvansville$19K
Adeel SiddiquiEvansville$16K
Samer AbbasEast Chicago$395K
James HermillerIndianapolis$307K
Woodrow CoreyIndianapolis$262K
Muzammil MusaniFort Wayne$184K
Dean FerreraEast Chicago$180K
Shashidhar DivakaruniMunster$97K
Navneet LatherNoblesville$83K
Michael BallIndianapolis$76K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →